Conmed (CNMD) Revenue (2010 - 2026)

Conmed (CNMD) has reported Revenue for 17 consecutive years, with $343.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue changed 0.33% year-over-year to $343.5 million; the trailing twelve-month figure through Jun 2026 stood at $1.4 billion (up 3.42% YoY), and the FY2025 full-year result was $1.4 billion, up 5.18% from the prior year.
• Revenue improved to $343.5 million in Q2 2026 per CNMD's latest filing, from $317.0 million in the prior quarter.
• Across five years, Revenue topped out at $373.2 million in Q4 2025 and bottomed at $242.3 million in Q1 2022.
• Historically, Revenue has averaged $312.9 million across 5 years, with a median of $317.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue dropped 8.43% in 2022, then jumped 30.37% in 2023.
• Over 5 years, Revenue stood at $250.9 million in 2022, then jumped by 30.37% to $327.0 million in 2023, then grew by 5.78% to $345.9 million in 2024, then gained by 7.88% to $373.2 million in 2025, then declined by 7.96% to $343.5 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $343.5 million, $317.0 million, and $373.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.